APPROACHES ACP Specialist Program vs Control: deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.268 | 0.258 | 0.278 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.269 | 0.259 | 0.279 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | -0.000832 | -0.0151 | 0.0134 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 0.997 | 0.945 | 1.05 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 0.996 | 0.926 | 1.07 | log | ClinicalTrials.gov | |
| Number needed to treat, for one fewer death from any cause on APPROACHES ACP Specialist Program than on Control | 1,200 | from the risk difference interval | the interval includes no difference | ClinicalTrials.gov |
Groups 2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | APPROACHES ACP Specialist Program | Enrolled facilities that will be trained in the APPROACHES Advance Care Planning (ACP) Specialist Program.~APPROACHES ACP Specialist Program: The APPROACHES Advance Care Planning (ACP) Specialist will work with nursing home leaders (in intervention arm facilities) to: i. Consolidate nursing home ACP procedures; ii. Train and educate staff; and iii. Facilitate ACP Specialist Program with patients who have Alzheimer's disease/related dementias and their family caregivers. | 2,005 | 7,474 | EG000 | ClinicalTrials.gov |
| Group 2 | Control | Enrolled facilities that will perform standard of care Advance Care Planning (ACP) procedures.~Standard of care: Standard of care Advance Care Planning (ACP) procedures | 1,980 | 7,358 | EG001 | ClinicalTrials.gov |
Harm 2
| Field | Value | Source |
|---|---|---|
| What it counts | Total, all-cause mortality | ClinicalTrials.gov |
| Time frame | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support | ClinicalTrials.gov |
| NCT number | NCT03323502 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | Alzheimer Disease, Dementia | ClinicalTrials.gov |
| Interventions | APPROACHES ACP Specialist Program, Standard of care | ClinicalTrials.gov |
| Lead sponsor | Indiana University | ClinicalTrials.gov |
| Results first posted | 2025-08-26 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT03323502?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.